This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Regulatory / Schall Law Firm investigates Abivax
Regulatory securities fraud investigation

Schall Law Firm investigates Abivax

Analysis based on 10 articles · First reported Jun 04, 2026 · Last updated Jun 10, 2026

Sentiment
-50
Attention
3
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is negatively impacted by the news of a securities fraud investigation into Abivax, leading to a sharp decline in Abivax's share price. This event highlights potential risks for investors in the biotechnology sector regarding clinical trial disclosures.

Biotechnology Legal Services
Event Summary

The The Schall Law Firm has announced an investigation into Abivax S.A. for potential violations of securities laws. The investigation stems from allegations that Abivax issued false and/or misleading statements or failed to disclose crucial information to investors. Specifically, Abivax's Phase 3 ABTECT trial for obefazimod reportedly revealed rare malignancy cases, which led to a sharp decline in Abivax's stock price on June 2, 2026. The The Schall Law Firm is encouraging shareholders who suffered losses to participate in the investigation, which could lead to a class action lawsuit.

Entities Involved
stock
Abivax
Abivax is facing a securities fraud investigation due to alleged false and/or misleading statements regarding its Phase 3 ABTECT trial for obefazimod, which revealed rare malignancy cases, causing its shares to fall sharply.
Importance 100.0 Sentiment -70.0
priv
The Schall Law Firm
The The Schall Law Firm is initiating an investigation into Abivax for securities law violations on behalf of its investors, potentially leading to a class action lawsuit.
Importance 80.0 Sentiment 20.0
per
Brian Schall
Brian Schall is a representative of the The Schall Law Firm and is encouraging investors to contact him regarding the investigation into Abivax.
Importance 60.0 Sentiment 20.0
index
Nasdaq-100
Nasdaq-100 is the exchange where Abivax shares are traded, and its stock price was affected by the news of the investigation.
Importance 10.0 Sentiment 0.0
Relationships
The Schall Law Firm related ↔ Brian Schall
The Schall Law Firm related ↔ Nasdaq-100
Brian Schall related ↔ Nasdaq-100
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.